CONMED Corporation
CNMD
$38.46
-$0.95-2.41%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 485.48% | -86.65% | 254.89% | -82.12% | -31.09% |
| Total Depreciation and Amortization | -5.14% | 0.19% | 1.74% | 9.92% | -7.61% |
| Total Amortization of Deferred Charges | 114.66% | -8.07% | -3.81% | -49.26% | 97.09% |
| Total Other Non-Cash Items | 162.46% | 86.62% | -66.04% | 8.20% | 176.15% |
| Change in Net Operating Assets | -175.12% | 222.61% | -2,835.38% | 102.66% | -2,075.52% |
| Cash from Operations | -13.69% | 84.27% | -29.86% | -4.16% | -15.36% |
| Capital Expenditure | 1.47% | 9.46% | -51.60% | 6.46% | -18.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Investing | -37.09% | 9.46% | -95.60% | 27.50% | -18.16% |
| Total Debt Issued | 11.98% | -16.78% | 20.88% | 10.67% | 4.90% |
| Total Debt Repaid | -5.61% | 7.40% | -17.21% | 2.91% | -10.06% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.03% | -0.05% | -0.10% | -0.05% | -0.23% |
| Other Financing Activities | -34.11% | 10.77% | -22.44% | 14.20% | -33.37% |
| Cash from Financing | 14.14% | -64.08% | 6.59% | 44.39% | -31.52% |
| Foreign Exchange rate Adjustments | 70.00% | -98.73% | 91.94% | 136.63% | -446.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -62.19% | 422.19% | -114.06% | 178.71% | -245.95% |